Balasubramanian is married to Shakti who is associated with ETV as a producer and the couple has two daughters.[3][4] The elder daughter, Katyayani is a research analyst and the younger one, Akhila works as a public health professional.[3][4] The family lives in Hyderabad.[3][5]
Positions
Balasubramanian is a visiting scientist at the National Eye Institute, Bethesda and is a senior Fellow of ophthalmology at the University of Melbourne.[2] He is the chairman of the Task Force on Stem Cell Research set up by the Department of Biotechnology of the Government of India.[5] He is a former president of the Indian Academy of Sciences (2007-2010)[4][8] and is the incumbent the chairman of the Biotechnology Advisory Council of the Government of Andhra Pradesh.[3] A former secretary general of The World Academy of Sciences,[3][4] he has served as the project coordinator of Translational Centre in Eye Diseases of Champalimaud Foundation (C-TRACER) and the Affordable Healthcare Project of the Wellcome Trust for finding solutions for the use of scaffolds for cultivating stem cells.[8] He is a former member of the International Human Rights Network of Academies and Scholarly Societies,[12] the International Basic Sciences Panel[13] of UNESCO and the International Chapter Affiliate Committee of the Association for Research in Vision and Ophthalmology (ARVO),[14] United States.[8] He has also served as an editorial board member of several international journals.[4][5] He had also been appointed as one of the honorary advisory committee members for the International Conference on Genome Biology 2019 (ICGB'19) by the School of Biological Sciences of Madurai Kamaraj University.[15]
Legacy
Balasubramanian started his research activities in 1965 focusing on the structure and functions of proteins and polypeptides[16] and worked on the thermodynamic analysis of their stability.[1][5][8] The focus of his research changed in 1984/85 when he started to work on ocular science and concentrated on crystallins of eye lens and their function as an agent in keeping the lens transparent.[17] His research revealed how cataract is caused when crystallins are damaged photochemically, thereby leading to diminished lenticular transparency.[1] He argued that the oxidative stress on the lens induces covalent chemical changes in the constituent molecules[3] and these changes lead to cataract.[1][4][5][8] He researched further on the subject to find out that, by supplementing antioxidants and cytoprotective substances, the progression of cataract can be slowed down.[4] These findings are known to have introduced a prophylactic approach to addressing the issue of cataract, which is reported to be the causal factor for 47.9 percent[18] of the blindness in the world.[1] Further, he attempted to identify the cataractostatic agents and proposed the benefits of tea polyphenols,[19]Ginko Biloba[20] and Withania somnifera extracts.[21] These substances contained antioxidants and cytoprotective compounds which slow down the progression of oxidative cataract and this was verified during experiments in animals.[1]
After the turn of the century, Balasubramanian and his colleagues started working on inherited eye diseases[8] and their molecular genetics.[4] The group carried out research on diseases such as congenital glaucoma[5][22] with a sampling set of over 400 families and this has helped in revealing 15 mutations in the gene CYP1B1, with mutation R368H being the most common one.[4][22] The research has also recorded the genotype–phenotype correlations and the structural changes occur in mutated protein[4][22] and these findings have assisted in clinical prediction of the disease and in early therapeutic intervention to avert blindness.[1]
Balasubramanian is now working on stem cell biology and its use in restoring lost vision.[23] He and his group have been successful in isolating the adult stem cells found in the limbus, around the cornea, and culturing them on human amniotic membrane.[8] These cultured stem cells were, later, used to produce corneal epithelia that can be stitched on to human eye. Clinical tests on 200 patients who lost eyesight due to chemical or fire burns returned significantly good results with vision restoration to 20/20 levels,[4] with or without subsequent corneal grafts or transplantation.[1] These tests are reported to be the largest successful human trial of adult stem cell therapy in the world.[1][4]
Balasubramanian has published 6 books[3] of which two books,[3] one on chemistry and the other in biotechnology, are prescribed text books for academic studies.[1][4][24] He is credited with over 450 articles,[3][4] published in peer reviewed national and international journals[2][25] and Microsoft Academic Search, an online repository of scientific articles, has listed 52 of them.[26] He has presented more than 170 scientific papers[1][3][4][5] and has contributed in popularizing science by writing columns in leading newspapers such as The Hindu and The Times of India since 1980.[3][4][24][27] On the academic front, he has assisted 16 doctoral students in their PhD studies.[5] His efforts are also reported behind the establishment of a vaccine unit at the Centre for Cellular and Molecular Biology and in designing a quality improvement program for the Sericulture Laboratory of the state government.[4]
He has delivered many award lectures in India and abroad. In 1985, he delivered the National Lecture of the University Grants Commission and the next year, the Prof. K. Venkataraman Endowment Lecture.[11] K. S. G. Doss Memorial Lecture and the SERC National Lecture were delivered in 1991 followed by Pasteur Centenary Lecture, R. P. Mitra Memorial Lecture and the Platinum Jubilee Lecture of the Indian Science Congress Association in 1995. Some of the other award lectures given by Balasubramanian are:[11]
^Yogendra Sharma; A. Gopalakrishna; D. Balasubramanian (January 2008). "ALTERATION OF DYNAMIC QUATERNARY STRUCTURE AND CALCIUM-BINDING ABILITY OF ß-CRYSTALLIN BY LIGHT". Photochemistry and Photobiology. 57 (4): 739–743. doi:10.1111/j.1751-1097.1993.tb02947.x. PMID8506401. S2CID35085602.
^"WHO". WHO. 2015. Archived from the original on 21 March 2006. Retrieved 23 January 2015.
^Geetha Thiagarajan; Sushil Chandani; C. Sivakama Sundan; S. Harinarayana Rao; Ajay V. Kulkarni; D. Balasubrmanian (September 2001). "Antioxidant Properties of Green and Black Tea, and their Potential Ability to Retard the Progression of Eye Lens Cataract". Experimental Eye Research. 73 (3): 392–401. doi:10.1006/exer.2001.1049. PMID11520114. S2CID23427305.
^Geetha Thiagarajan; Sushil Chandani; Ayelet M. Samuni; S. Harinarayana Rao; Krish Chandrasekharan; D. Balasubrmanian (October 2002). "Molecular and Cellular Assessment of Ginkgo Biloba Extract as a Possible Ophthalmic Drug". Experimental Eye Research. 75 (4): 421–430. doi:10.1006/exer.2002.2035. PMID12387790.